Marker Therapeutics, Inc. Revenue 2017–2025
Marker Therapeutics, Inc. annual/quarterly revenue history and growth rate from 2017 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Marker Therapeutics, Inc. revenue for the quarter ending March 31, 2026 was 751691, a 115.32% increase year-over-year.
- Marker Therapeutics, Inc. revenue for the twelve months ending March 31, 2026 was 3.2 M, a 30.50% decrease year-over-year.
- Marker Therapeutics, Inc. annual revenue for 2025 was 3.5 M, a 46.19% decrease from 2024.
- Marker Therapeutics, Inc. annual revenue for 2024 was 6.6 M, a 99.06% increase from 2023.
- Marker Therapeutics, Inc. annual revenue for 2023 was 3.3 M, a 5.76% decrease from 2022.
- Marker Therapeutics, Inc. annual revenue for 2022 was 3.5 M.
Marker Therapeutics, Inc. (MRKR) — Frequently Asked Questions
Marker Therapeutics, Inc. (MRKR) is a publicly traded US company. It has a market capitalization of $22M. In fiscal 2025 it reported revenue of $4M and net income of -$12M. Explore MRKR's stock price, financial statements, earnings history, margins and key ratios below.
What is Marker Therapeutics, Inc.'s market cap?
Marker Therapeutics, Inc. (MRKR) has a market capitalization of $22M.
What is the MRKR stock price?
MRKR trades at $1.43 (+1.42% on the day).
How much revenue does Marker Therapeutics, Inc. make?
Marker Therapeutics, Inc. reported revenue of $4M in fiscal 2025.
Is MRKR profitable?
In fiscal 2025, Marker Therapeutics, Inc. reported net income of -$12M.